Injectable Immune-Regulating Mesenchymal Stem Cells Hydrogel for Localized Scleroderma Treatment
ACS Nano · 07.10.2025 · 19 (39) · 34785-34796
DOI: 10.1021/acsnano.5c10112 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 24.09.2025. Verfasst von Rui Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Institute of Translational Medicine, Nanjing Drum Tower Hospital, Affiliated hospital of Medical School, N…. Hauptthemen laut MEDLINE: Hydrogels, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Scleroderma, Localized. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science and Technology Foundation of Shenzhen City, National Natural Science Foundation of China.
Abstract (Originalsprache)
Bioactive hydrogels with anti-inflammatory, antioxidant, and pro-angiogenic properties are crucial for unlocking the full potential of mesenchymal stem cells (MSCs) therapy for scleroderma treatment. Here, drawing inspiration from the adhesion, antioxidant, and inflammation regulation ability of green tea, we introduce an injectable MSCs hydrogel containing immune-regulating polyphenol nanozymes to treat localized scleroderma. The hydrogel is constructed based on the dynamic Schiff reaction, which could endow it with injectability, self-healing function, and tissue adhesion. The introduction of natural polyphenol-based nanozymes can enhance the reactive oxygen species (ROS) scavenging and anti-inflammatory capabilities of the hydrogel and facilitate macrophage transformation. Besides, the hydrogel provides a conducive three-dimensional (3D) growth environment for MSCs in vitro, effectively promoting the ability of MSCs in the antifibrosis, vascular endothelial cells migration, and neovascularization. We have demonstrated that our hydrogel could accelerate the recovery of scleroderma lesions by inhibiting the expression of pro-inflammatory and fibrotic factors, promoting angiogenesis, remodeling skin appendages, and enhancing the expression of anti-inflammatory factors in a mouse scleroderma model. These results suggest that our injectable polyphenol nanozyme MSCs hydrogel presents a potential therapeutic strategy for managing scleroderma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Institute of Translational Medicine, Nanjing Drum Tower Hospital, Affiliated hospital of Medical School, Nanjing University, Nanjing 210008, China.
- Department of Biomedical Engineering, School of Medicine, Shenzhen University, Shenzhen, Guangdong 518000, China.
- School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
ORCID-Profile: Rui Liu, Bin Kong, Junjie Lu, Yuanjin Zhao
Förderung
- National Key Research and Development Program of China
- Science and Technology Foundation of Shenzhen City
- National Natural Science Foundation of China
- Shenzhen Medical Research Fund
- Jiangsu Funding Program for Excellent Postdoctoral Talent
- Key Projects of the Jiangsu Basic Research Program
- Guangdong Basic and Applied Basic Research Foundation
- Clinical Trials from Nanjing Drum Tower Hospital
Zitieren
APA
Liu, R., Kong, B., Lu, J., Zhao, Y., & Sun, L. (2025). Injectable Immune-Regulating Mesenchymal Stem Cells Hydrogel for Localized Scleroderma Treatment. ACS Nano, 19(39), 34785-34796. https://doi.org/10.1021/acsnano.5c10112
Vancouver
Liu R, Kong B, Lu J, Zhao Y, Sun L. Injectable Immune-Regulating Mesenchymal Stem Cells Hydrogel for Localized Scleroderma Treatment. ACS Nano. 2025;19(39):34785-34796. doi:10.1021/acsnano.5c10112
BibTeX
@article{Liu2025,
author = {Liu, Rui and Kong, Bin and Lu, Junjie and Zhao, Yuanjin and Sun, Lingyun},
title = {Injectable Immune-Regulating Mesenchymal Stem Cells Hydrogel for Localized Scleroderma Treatment},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {39},
pages = {34785--34796},
doi = {10.1021/acsnano.5c10112}
}
EUVIMED